# Safety and Efficiency of the PacePress to Prevent Hemorrhagic Complications in Patients Undergoing CIED Implantation.

> **NCT05292326** · NA · TERMINATED · sponsor: **Medinice S.A.** · enrollment: 122 (actual)

## Conditions studied

- Hemorrhagic Complications
- Hematoma
- Hemorrhage
- Pathologic Processes

## Interventions

- **DEVICE:** PacePress
- **DEVICE:** standard compression band

## Key facts

- **NCT ID:** NCT05292326
- **Lead sponsor:** Medinice S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-25
- **Primary completion:** 2025-03-14
- **Final completion:** 2025-03-14
- **Target enrollment:** 122 (ACTUAL)
- **Why stopped:** The study was stopped at interim analysis due to significantly better outcomes with PacePress, consistent with the predefined statistical methodology.
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05292326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05292326, "Safety and Efficiency of the PacePress to Prevent Hemorrhagic Complications in Patients Undergoing CIED Implantation.". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05292326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*